OTC •
Healthcare •
Biotechnology •
Quote as of 07/21/2026 15:05
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization22.23 mln
Float108 mln
Earnings Date06/25/2025
Piotroski F-Score
4
/ 9
Borderline
Relative Strength
96
/ 100
Top performer
Debt / Equity
-0.12
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
BetterLife Pharma Inc. is a Canadian biotechnology company working to develop treatments for mental health conditions and viral infections. Its lead mental health candidate, BETR-001, is a non-hallucinogenic compound derived from LSD that targets depression, anxiety, and related neurological disorders. The company also has two interferon-based therapies in development ? a topical cream for HPV-related cervical disease and an inhaled formulation aimed at COVID-19 and other respiratory infections, both of which have completed Phase II clinical trials. Founded in 2002 and based in Vancouver, the company operates under a name it adopted in late 2019, having previously been known as Pivot Pharmaceuticals Inc.
